InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Berns Paul l, Director. Director active across 6 companies, notably Jazz Pharmaceuticals plc. Cumulatively, 16 disclosures have been published. Breakdown: 1 buy · 6 sells. Total volume traded: €240k. History available since 5 August 2021. The latest transaction was filed on 17 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Berns Paul l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
1,250,000 sharesCommon StockSEC:0001012975-26-000565:0
Canonical exit: 20 Sept 2026 (T+90)
13,792,035 sharesCommon StockSEC:0001193125-26-277936:0
20,706 sharesCommon StockSEC:0001193125-26-277936:1
9,819 shares@ US$3.509456.5% of flowCommon StockSEC:0001610717-26-000052:0
4,031 sharesCommon StockSEC:0001193125-25-280813:0
13,871 shares@ US$1.6919100.0% of flowCommon StockSEC:0001610717-25-000031:0
7,523,682 sharesCommon StockSEC:0000950170-25-012583:0
133,097 shares0Common StockSEC:0001610717-24-000555:0
171,250 shares0Common StockSEC:0001610717-24-000066:0
627,000 sharesCommon StockSEC:0000899243-23-020307:0
627,000 sharesCommon StockSEC:0000899243-21-049123:0
1,450 shares@ US$154.00100.0% of flowOrdinary SharesSEC:0001765581-21-000096:0
14,584 sharesCommon StockSEC:0001209191-16-096104:0
80 sharesCommon StockSEC:0001209191-16-089483:0
233 sharesCommon StockSEC:0001209191-16-089483:2
2,220 sharesCommon StockSEC:0001209191-16-089483:1
16 of 16 declarations
About Berns Paul l
BERNS PAUL L is Administrateur and has 16 filings in total. Across the 16 recent filings held, they span 2016-01-05 to 2026-06-24 and show sales of EUR 240128, with filings tied notably to Jazz Pharmaceuticals plc, Neumora Therapeutics, Inc. and Kardigan, Inc.
